Detalles de la búsqueda
1.
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical Trials.
Oncologist
; 29(5): 422-430, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349736
2.
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survival.
Eur Radiol
; 33(10): 7284-7293, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099174
3.
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer.
Curr Oncol Rep
; 25(9): 1017-1029, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37378881
4.
Antibody-drug conjugates for lung cancer in the era of personalized oncology.
Semin Cancer Biol
; 69: 268-278, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31899248
5.
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer
; 128(16): 3067-3079, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727053
6.
Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.
Semin Cancer Biol
; 56: 87-99, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128510
7.
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1189, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347358
8.
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1177-1187, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140762
9.
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.
Future Oncol
; 16(23): 1751-1766, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539551
10.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796151
11.
Osimertinib.
Recent Results Cancer Res
; 211: 257-276, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30069773
12.
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series.
J Neurooncol
; 129(2): 355-61, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324494
13.
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers.
Res Sq
; 2024 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38313284
14.
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 8: e2300439, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330262
15.
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300371, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330261
16.
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
Cancer Discov
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38564707
17.
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
J Clin Oncol
; 42(11): 1311-1321, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38207230
18.
The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks.
Drugs Context
; 122023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37168875
19.
Immune-Related Thyroiditis in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors: Imaging Features and Clinical Implications.
Cancers (Basel)
; 15(3)2023 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765606
20.
Optimizing the safety of antibody-drug conjugates for patients with solid tumours.
Nat Rev Clin Oncol
; 20(8): 558-576, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296177